サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675338

馬用ヘルスケア市場：製品別、適応症別、流通チャネル別、地域別、2025-2033年

Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
馬用ヘルスケア市場：製品別、適応症別、流通チャネル別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

馬用ヘルスケア市場の世界市場規模は2024年に16億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに26億米ドルに達し、2025年から2033年の間に5.31%の成長率（CAGR）を示すと予測しています。馬の人口の急激な増加、馬の健康や適切な栄養摂取に関する飼い主の意識の高まり、高度な画像診断技術の活用などが市場を牽引する主な要因となっています。

馬用ヘルスケアは、馬の病気の診断、治療、予防に焦点を当てた獣医学の一分野です。ワクチン、駆虫薬、局所治療薬、関節サプリメント、プレバイオティクス、ハエ取りスプレー、蹄コンディショナー、防腐剤、パフォーマンス添加剤など、さまざまな製品を利用します。馬用ヘルスケアには、予防ケア、疾病管理、跛行治療、生殖ケア、口腔衛生、リハビリテーション、行動問題への対処などが含まれます。全体的な健康状態を改善し、将来の合併症を予防し、病気の早期発見を可能にし、繁殖を成功させ、寿命を延ばし、跛行、歯の問題、感染症、肥満、ヘルペス、狂犬病などの重篤な病気のリスクを軽減します。

馬用ヘルスケア市場傾向：

競馬、農業、コンパニオンとして馬が広く利用されているため、馬の人口が急速に増加していることが、市場成長を促進する主な要因の1つです。予防ケア、繁殖サービス、リハビリテーションセンター、ワクチン、健康補助食品などの馬用ヘルスケアサービスおよび製品は、最適なパフォーマンスを確保し、合併症を予防し、怪我から守り、病気のリスクを軽減するために広く使用されています。これに加えて、馬の健康と適切な栄養摂取の重要性に関する馬主の意識の高まりが、もう一つの成長促進要因として作用しています。さらに、動物福祉を支援し、責任ある飼養を促進し、質の高いヘルスケア施設へのアクセスを提供するためのさまざまな政府イニシアチブの実施は、市場成長にプラスの影響を与えています。さらに、デジタルX線撮影、超音波検査、内視鏡検査などの高度な画像診断技術の活用により、馬体の詳細な断面画像が得られるため、筋骨格系の損傷、跛行、内部疾患の診断が可能になり、市場の成長に寄与しています。このほか、最近の馬用ウェアラブル健康モニタリング機器の開発動向は、バイタルサイン、活動レベル、行動の継続的なモニタリングを可能にし、あらゆる健康問題の早期発見を容易にしており、市場成長に弾みをつけています。さらに、レース、ジャンプ、馬場馬術、耐久乗馬などの馬術スポーツの増加が市場成長を後押ししています。その他の要因としては、消費者の支出能力の上昇、ペットの人間化という新たな動向、広範な研究開発（R&D）活動、eコマース産業の急速な拡大などが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 世界の馬用ヘルスケア市場はこれまでどのように推移してきたのか？
  • 世界の馬用ヘルスケア市場における促進要因、抑制要因、機会は何か？
  • 各促進要因、抑制要因、機会が世界の馬用ヘルスケア市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な馬用ヘルスケア市場はどの国か？
  • 製品別の市場内訳は？
  • 馬用ヘルスケア市場で最も魅力的な製品はどれですか？
  • 適応症別の市場内訳は？
  • 馬用ヘルスケア市場で最も魅力的な適応症は？
  • 流通チャネル別の市場内訳は？
  • 馬用ヘルスケア市場で最も魅力的な流通チャネルは？
  • 世界の馬用ヘルスケア市場の競合構造は？
  • 世界の馬用ヘルスケア市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の馬用ヘルスケア市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 医薬品
    • 主要セグメント
      • 抗炎症薬
      • 寄生虫駆除薬
      • その他
  • ワクチン
    • 主要セグメント
      • 生弱毒化ワクチン
      • 組換えワクチン
      • その他
  • 薬用飼料添加物
  • 診断
  • その他

第7章 市場内訳：適応症別

  • 筋骨格障害
  • 寄生虫駆除
  • 馬ヘルペスウイルス
  • 馬脳脊髄炎
  • 馬インフルエンザ
  • ウエストナイルウイルス
  • 破傷風
  • 狂犬病
  • その他

第8章 市場内訳：流通チャネル別

  • 動物病院・診療所
  • 小売薬局・ドラッグストア

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Esaote SpA
    • Hallmarq Veterinary Imaging
    • IDEXX Laboratories Inc.
    • Merck & Co. Inc.
    • Vetoquinol S.A.
    • Zoetis Inc
図表

List of Figures

  • Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
  • Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Equine Healthcare Market: Competitive Structure
  • Table 7: Global: Equine Healthcare Market: Key Players
目次
Product Code: SR112025A7779

The global equine healthcare market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.31% during 2025-2033. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

Equine Healthcare Market Trends:

The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

Key Market Segmentation:

Product Insights:

  • Drugs
  • Anti-Inflammatory Drugs
  • Parasiticide Drugs
  • Others
  • Vaccines
  • Live Attenuated Vaccine
  • Recombinant Vaccine
  • Others
  • Medicated Feed Additives
  • Diagnostics
  • Others

Indication Insights:

  • Musculoskeletal Disorders
  • Parasite Control
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Rabies
  • Others

Distribution Channel Insights:

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global equine healthcare market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global equine healthcare market?
  • What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
  • What are the key regional markets?
  • Which countries represent the most attractive equine healthcare market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the equine healthcare market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the equine healthcare market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the equine healthcare market?
  • What is the competitive structure of the global equine healthcare market?
  • Who are the key players/companies in the global equine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Equine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-Inflammatory Drugs
      • 6.1.2.2 Parasiticide Drugs
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Live Attenuated Vaccine
      • 6.2.2.2 Recombinant Vaccine
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parasite Control
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Equine Herpes Virus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Equine Encephalomyelitis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Equine Influenza
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 West Nile Virus
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Tetanus
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Rabies
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Ceva
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Dechra Pharmaceuticals PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Elanco Animal Health Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Esaote SpA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Hallmarq Veterinary Imaging
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 IDEXX Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Vetoquinol S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zoetis Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.